Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study)

oleh: Carlos Suso-Ribera, Azucena García-Palacios, Juan P Sanabria-Mazo, Ariadna Colomer-Carbonell, Francesco D'Amico, Michael Maes, Xavier Borràs, Albert Feliu-Soler, Juan V Luciano, Jordi Muchart, Josep Munuera, Halbert Hernández-Negrín, Jarred W Younger, Antoni Rozadilla-Sacanell

Format: Article
Diterbitkan: BMJ Publishing Group 2022-01-01

Deskripsi

No description available for this item.